2013•Guide of China MedicineRequires access

Atorvastatin Clinical Efficacy and Safety Explore Statin plus Fenofibrate Treatment of Acute Coronary Syndrome

Zhou Wei-hong

Open publisher page 0 citations

Abstract

Objective To investigate the atorvastatin statin plus fenofibrate clinical efficacy and safety in the treatment of acute coronary syndrome.Methods Hospital Cardiology,treated 90 patients with acute coronary syndrome,treatment is divided into observation group and control group,the control group using a single drug atorvastatin statin treatment,the observation group on the basis of the control group plus atorvastatin,one year of continuous treatment,the two groups were compared lipid changes and cardiovascular events.Results Observation group were significantly improved lipid parameters,a low incidence of adverse cardiovascular events compared with the control group of patients was statistically significant(P0.05) difference.Conclusion Atorvastatin statin plus fenofibrate significant clinical efficacy for the treatment of acute coronary syndrome,the two drugs have a synergistic,with good security.

About this research paper

What this paper is about

Objective To investigate the atorvastatin statin plus fenofibrate clinical efficacy and safety in the treatment of acute coronary syndrome.Methods Hospital Cardiology,treated 90 patients with acute coronary syndrome,treatment is divided into observation group and control group,the control group using a single drug atorvastatin statin treatment,the observation group on the basis of the control group plus atorvastatin,one year of continuous treatment,the two groups were compared lipid changes and cardiovascular events.Results Observation group were significantly improved lipid parameters,a low incidence of adverse cardiovascular events compared with the control group of patients was statistically significant(P0.05) difference.Conclusion Atorvastatin statin plus fenofibrate significant clinical efficacy for the treatment of acute coronary syndrome,the two drugs have a synergistic,with good security.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the atorvastatin statin plus fenofibrate clinical efficacy and safety in the treatment of acute coronary syndrome.Methods Hospital Cardiology,treated 90 patients with acute coronary syndrome,treatment is divided into observation group and control group,the control group using a single drug atorvastatin statin treatment,the observation group on the basis of the control group plus atorvastatin,one year of continuous treatment,the two groups were compared lipid changes and cardiovascular events.Results Observation group were significantly improved lipid parameters,a low incidence of adverse cardiovascular events compared with the control group of patients was statistically significant(P0.05) difference.Conclusion Atorvastatin statin plus fenofibrate significant clinical efficacy for the treatment of acute coronary syndrome,the two drugs have a synergistic,with good security.

Key concepts: Medicine, Atorvastatin, Fenofibrate, Acute coronary syndrome, Statin, Internal medicine, Incidence (geometry), Drug

Related papers

Back to paper searchBrowse research topicsOriginal source
Atorvastatin Clinical Efficacy and Safety Explore Statin plus Fenofibrate Treatment of Acute Coronary Syndrome — Research Paper | ScholarLens